Effect of Exercise Versus Metformin among Nigerians with Prediabetes: A Randomised Controlled Trial
Abstract
BACKGROUND: Prediabetes is an important risk factor for the development of type 2 diabetes and is common in Nigeria. Prediabetes often progresses to type 2 diabetes but effective intervention can reverse the carbohydrate intolerance associated with the condition. No studies have been reported among Nigerians on the natural outcome or effect of intervention in prediabetes.
OBJECTIVE: To determine and compare the effect of moderate exercise and metformin on glucose tolerance among the participants with prediabetes.
METHODOLOGY: Using a randomized placebo-controlled design, 54 Nigerians with prediabetes were selected using simple random sampling. They were offered treatment with metformin, moderate exercise, or placebo and followed up for 12 weeks. Plasma glucose levels were assessed before and after the interventions and the outcome was compared.
RESULTS: Forty-nine participants with prediabetes completed the study. Compared to placebo the exercise group had a significant decrease in glycaemic level from the baseline, FPG=5.1mmol/L (6.4% reduction) and 2HPGL=7.6mm/L (20.5% reduction) p-value<0.05. The metformin group also had a significant decrease in glycaemic level from the baseline, FPG=5.1mmol/L (13.3% reduction) and 2HPGL=7.9mmol/L (12.4% reduction) p-value<0.05. Diabetes risk reduction for exercise and metformin interventions were 50% and 40%respectively.
CONCLUSION: Among Nigerians with prediabetes, moderate exercise, and metformin interventions have significantly…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.